NCT01607879 2023-09-22
Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
Medical College of Wisconsin
Phase 2 Completed
Clinical Trials
12 trialsNCT01179217 2020-08-19
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Emmaus Medical, Inc.
Phase 3 Completed
NCT01983969 2020-01-27
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT00772824 2018-07-17
Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients
Banaras Hindu University
Phase 4 Completed
NCT00195013 2018-06-06
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Weill Medical College of Cornell University
Phase 3 Completed
NCT03015077 2017-01-10
Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Completed
NCT00365768 2016-09-09
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Columbia University
Phase 2 Completed
NCT00003170 2016-07-14
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00255229 2016-02-25
Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea
AHS Cancer Control Alberta
Phase 2 Completed
NCT01087658 2013-06-21
GLUTOX
Sanofi
Phase 3 Completed
NCT00455247 2013-06-05
Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects
Société des Produits Nestlé (SPN)
Phase 3 Completed
NCT00003898 2011-03-01
Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation
Roswell Park Cancer Institute
Phase 2 Completed